RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eurofins-Cerep Stock

Eurofins-Cerep Dividend 2024

Eurofins-Cerep Dividend

0 EUR

Eurofins-Cerep Dividend yield

Ticker

ALECR.PA

ISIN

FR0013256518

WKN

A2DT0B

How much dividend does Eurofins-Cerep 2024 pay?

According to the latest status from December 2024, Eurofins-Cerep paid a total of 0 EUR per share in dividends within the last 12 months. With the current Eurofins-Cerep price of 18,000 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Eurofins-Cerep Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Eurofins-Cerep Dividend Safe?

Eurofins-Cerep has been increasing the dividend for 0 years.

Over the past 10 years, Eurofins-Cerep has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Eurofins-Cerep's Dividend Distributions

Eurofins-Cerep’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Eurofins-Cerep's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Eurofins-Cerep's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Eurofins-Cerep’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Eurofins-Cerep Aktienanalyse

What does Eurofins-Cerep do?

Eurofins-Cerep SA is a globally renowned biotechnology company that was founded in 1993. With its headquarters in Paris, France, the company operates over 47 locations worldwide and employs over 45,000 employees. The company specializes in the development and commercialization of innovative biological technologies for use in the pharmaceutical industry. Eurofins-Cerep focuses on the discovery of new drugs for the treatment of diseases such as cancer, Alzheimer's, Parkinson's, and diabetes. The business model of Eurofins-Cerep is based on three pillars: services, product sales, and research and development offerings. Under the "services" division, the company offers extensive pharmacological and biological testing and screening procedures for drug compounds to its customers. Eurofins-Cerep has a wide range of assays and tests that allow customers to assess and optimize the efficacy and safety of their drug compounds. The "product sales" division includes the manufacturing and distribution of over 1,000 different biological reagents, antibodies, and other products for biomedical research. The company specializes in producing reagents used in drug development, such as G-protein coupled receptors (GPCRs). The third pillar of Eurofins-Cerep's business model consists of research and development services for customers and partners. The company supports customers in identifying new drug compounds and developing drug candidates up to market approval. The company has various divisions, including the Cerep division, which specializes in the evaluation of potential drug candidates and associated toxicology. The Eurofins Pharma Discovery Services division offers advanced drug optimization and screening services by providing customized approaches to drug development. The Eurofins BioPharma Services division is a leading provider of complete solutions in the pharmaceutical development and GxP laboratories. The company is also active in other areas such as the environment and the food industry. Eurofins-Cerep has made several acquisitions in the past, including the acquisition of XDS Laboratories, a leading provider of clinical laboratory services, and EAG Laboratories, a highly specialized analysis and testing service unit. Overall, Eurofins-Cerep SA has achieved numerous milestones in the past 28 years and has become one of the world's leading providers of biological screening and analysis technologies. The company remains committed to offering its customers innovative biological technologies and maintaining its reputation as a reliable partner in the pharmaceutical industry. Eurofins-Cerep is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Eurofins-Cerep stock

How much dividend does Eurofins-Cerep pay?

Over the past 12 months, Eurofins-Cerep paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eurofins-Cerep is expected to pay a dividend of 0 EUR.

What is the dividend yield of Eurofins-Cerep?

The current dividend yield of Eurofins-Cerep is .

When does Eurofins-Cerep pay dividends?

Eurofins-Cerep pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eurofins-Cerep?

Eurofins-Cerep paid dividends every year for the past 0 years.

What is the dividend of Eurofins-Cerep?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eurofins-Cerep located?

Eurofins-Cerep is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurofins-Cerep kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurofins-Cerep from 12/12/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Eurofins-Cerep pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Eurofins-Cerep in the year 2023?

In the year 2023, Eurofins-Cerep distributed 0 EUR as dividends.

In which currency does Eurofins-Cerep pay out the dividend?

The dividends of Eurofins-Cerep are distributed in EUR.

Andere Kennzahlen von Eurofins-Cerep

Our stock analysis for Eurofins-Cerep Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurofins-Cerep Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.